Expression of Activating Transcription Factor 3 (ATF 3) and caspase 3 in Schwann cells and axonal outgrowth after sciatic nerve repair in diabetic BB rats

Neuroscience Letters

Volumn 515, Issue 1, 2012, Pages 34-38

  Stenberg, Lena ^a   Kanje, Martin ^a   Dolezal, Katarina ^a   Dahlin, Lars B ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

ATF3; BB rat; Caspase 3; Diabetes; Nerve regeneration; Schwann cell

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CASPASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; IMMUNOHISTOCHEMISTRY; NERVE REGENERATION; NEUROFILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCHWANN CELL; SCIATIC NERVE; SCIATIC NEUROPATHY; SIGNAL TRANSDUCTION; WISTAR RAT;

ACTIVATING TRANSCRIPTION FACTOR 3; ANIMALS; AXONS; CASPASE 3; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; RATS; RATS, INBRED BB; RATS, WISTAR; SCHWANN CELLS; SCIATIC NEUROPATHY;

EID: 84859437979     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.03.011     Document Type: Article

References (25)

1. Cai L., Li W., Wang G., Guo L., Jiang Y., Kang Y.J. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 2002, 51:1938-1948.
2. Dahlin L.B., Stenberg L., Luthman H., Thomsen N.O. Nerve compression induces activating transcription factor 3 in neurons and Schwann cells in diabetic rats. Neuroreport 2008, 19:987-990.
3. Duran-Jimenez B., Dobler D., Moffatt S., Rabbani N., Streuli C.H., Thornalley P.J., Tomlinson D.R., Gardiner N.J. Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes. Diabetes 2009, 58:2893-2903.
4. Gumy L.F., Bampton E.T., Tolkovsky A.M. Hyperglycaemia inhibits Schwann cell proliferation and migration and restricts regeneration of axons and Schwann cells from adult murine DRG. Mol. Cell. Neurosci. 2008, 37:298-311.
5. Kamijo M., Merry A.C., Akdas G., Cherian P.V., Sima A.A. Nerve fiber regeneration following axotomy in the diabetic biobreeding Worcester rat: the effect of ARI treatment. J. Diabetes Complications 1996, 10:183-191.
6. Kamiya H., Zhangm W., Sima A.A. Apoptotic stress is counterbalanced by survival elements preventing programmed cell death of dorsal root ganglions in subacute type 1 diabetic BB/Wor rats. Diabetes 2005, 54:3288-3295.
7. Lindwall C., Dahlin L., Lundborg G., Kanje M. Inhibition of c-Jun phosphorylation reduces axonal outgrowth of adult rat nodose ganglia and dorsal root ganglia sensory neurons. Mol. Cell. Neurosci. 2004, 27:267-279.
8. Martensson L., Gustavsson P., Dahlin L.B., Kanje M. Activation of extracellular-signal-regulated kinase-1/2 precedes and is required for injury-induced Schwann cell proliferation. Neuroreport 2007, 18:957-961.
9. Middlemas A., Delcroix J.D., Sayers N.M., Tomlinson D.R., Fernyhough P. Enhanced activation of axonally transported stress-activated protein kinases in peripheral nerve in diabetic neuropathy is prevented by neurotrophin-3. Brain 2003, 126:1671-1682.
10. Nathan D.M. Long-term complications of diabetes mellitus. N. Engl. J. Med. 1993, 328:1676-1685.
11. Obrosova I.G. Diabetes and the peripheral nerve. Biochim. Biophys. Acta 2009, 1792:931-940.
12. Oya T., Zhao Y.L., Takagawa K., Kawaguchi M., Shirakawa K., Yamauchi T., Sasahara M. Platelet-derived growth factor-b expression induced after rat peripheral nerve injuries. Glia 2002, 38:303-312.
13. Patterson C.C., Dahlquist G.G., Gyurus E., Green A., Soltesz G. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009, 373:2027-2033.
14. Pawson E.J., Duran-Jimenez B., Surosky R., Brooke H.E., Spratt S.K., Tomlinson D.R., Gardiner N.J. Engineered zinc finger protein-mediated VEGF-a activation restores deficient VEGF-a in sensory neurons in experimental diabetes. Diabetes 2010, 59:509-518.
15. Pierson C.R., Zhang W., Murakawa Y., Sima A.A. Insulin deficiency rather than hyperglycemia accounts for impaired neurotrophic responses and nerve fiber regeneration in type 1 diabetic neuropathy. J. Neuropathol. Exp. Neurol. 2003, 62:260-271.
16. Russell J.W., Sullivan K.A., Windebank A.J., Herrmann D.N., Feldman E.L. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol. Dis. 1999, 6:347-363.
17. Saito H., Dahlin L.B. Expression of ATF3 and axonal outgrowth are impaired after delayed nerve repair. BMC Neurosci. 2008, 9:88.
18. Saito H., Kanje M., Dahlin L.B. Delayed nerve repair increases number of caspase 3 stained Schwann cells. Neurosci. Lett. 2009, 456:30-33.
19. Sango K., Saito H., Takano M., Tokashiki A., Inoue S., Horie H. Cultured adult animal neurons and schwann cells give us new insights into diabetic neuropathy. Curr. Diabetes Rev. 2006, 2:169-183.
20. Sima A.A. New insights into the metabolic and molecular basis for diabetic neuropathy. Cell. Mol. Life Sci. 2003, 60:2445-2464.
21. Stenberg L., Kanje M., Martensson L., Dahlin L.B. Injury-induced activation of ERK 1/2 in the sciatic nerve of healthy and diabetic rats. Neuroreport 2011, 22:73-77.
22. Tomlinson D.R., Gardiner N.J. Diabetic neuropathies: components of etiology. J. Peripher. Nerv. Syst. 2008, 13:112-121.
23. Tsuda Y., Kanje M., Dahlin L.B. Axonal outgrowth is associated with increased ERK 1/2 activation but decreased caspase 3 linked cell death in Schwann cells after immediate nerve repair in rats. BMC Neurosci. 2011, 12:12.
24. Yi C., Dahlin L.B. Impaired nerve regeneration and Schwann cell activation after repair with tension. Neuroreport 2010, 21:958-962.
25. Zhang W., Kamiya H., Ekberg K., Wahren J., Sima A.A. C-peptide improves neuropathy in type 1 diabetic BB/Wor-rats. Diabetes Metab. Res. Rev. 2007, 23:63-70.